Trifecta Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Trifecta Capital Advisors's BSX Position: Q3 2026 in Review
Trifecta Capital Advisors reduced its Boston Scientific (BSX) stake by 3% in Q3 2026, selling an estimated $417 and leaving 295 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #237.
Trifecta Capital Advisors first reported a position in BSX in Q4 2022 and has held it in 16 quarters since. The position peaked at $4.99M in Q2 2025. 1,512 funds tracked by Wall St. Rank hold BSX as of Q3 2026.
- Trifecta Capital Advisors held 295 shares of Boston Scientific worth $12.9K as of Q3 2026.
- Trifecta Capital Advisors sold 9 Boston Scientific shares in Q3 2026, an estimated $417.
- Boston Scientific made up ﹤0.01% of Trifecta Capital Advisors's portfolio in Q3 2026, its #237 holding.
- Trifecta Capital Advisors first reported a position in Boston Scientific in Q4 2022 and has held it in 16 quarters since.
- Trifecta Capital Advisors's Boston Scientific position peaked at $4.99M in Q2 2025.
- 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.
Based on Trifecta Capital Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.